Cite
Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult
MLA
Jung Bin Kim, et al. “Administration of the P38 MAPK Inhibitor SB203580 Affords Brain Protection with a Wide Therapeutic Window against Focal Ischemic Insult.” Journal of Neuroscience Research, vol. 73, no. 4, Aug. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....58b0be449a7b9e8a764ee29521de63cb&authtype=sso&custid=ns315887.
APA
Jung Bin Kim, Chun Shu Piao, Ja-Kyeong Lee, & Pyung Lim Han. (2003). Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult. Journal of Neuroscience Research, 73(4).
Chicago
Jung Bin Kim, Chun Shu Piao, Ja-Kyeong Lee, and Pyung Lim Han. 2003. “Administration of the P38 MAPK Inhibitor SB203580 Affords Brain Protection with a Wide Therapeutic Window against Focal Ischemic Insult.” Journal of Neuroscience Research 73 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....58b0be449a7b9e8a764ee29521de63cb&authtype=sso&custid=ns315887.